SEBELA PHARMACEUTICALS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Jan 2024)
What this means for you
Registered since 27 Jun 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86980925
- Registration number
- 5233626
- Mark type
- Stylized text
- Filed
- 30 Sept 2015
- Published for opposition
- 12 Apr 2016
- Registered
- 27 Jun 2017
- Attorney of record
- Jeffrey H. Handelsman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicated preparations, namely, for use in dermatology, [ gastroenterology, ] rheumatology, and for use in the treatment of psychiatric disorders
Owner
- SEBELA IRELAND LIMITED, DUBLIN, IE
- SEBELA INTERNATIONAL BERMUDA LIMITED, HAMILTON, BM
- Sebela International Limited, Hamilton, IE
- Sebela International Limited, Hamilton, IE
- Sebela International Limited, Hamilton, IE
Prosecution history
- 10 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Jan 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jul 2023 — TEAS SECTION 8 & 15 RECEIVED
- 27 Jun 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Jul 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Jul 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Jun 2017 — REGISTERED-PRINCIPAL REGISTER
- 24 May 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 May 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Apr 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Apr 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Apr 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Apr 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Mar 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED